IndraLab

Statements


P5091 decreases the amount of CTNNB1. 2 / 2
| 2

reach
"As shown in Fig. 4 A and B, P5091 treatment downregulated β-catenin levels in these three cell lines in a dose-dependent manner."

reach
"Results of cytoplasmic and nuclear fraction assays and immunofluorescence assays reflected that P5091, to some extent, reduced β-catenin level of the cytoplasm and nucleus in HCT116 and SW480 cells ( [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"